We provide you with 20 years of free, institutional-grade data for DXCM stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of DXCM. Explore the full financial landscape of DXCM stock.
| Reported Date | CIK | Ticker | Type | |
|---|---|---|---|---|
| 2025-07-30 | 1093557 | DXCM | 10-Q | Url |
| 2025-05-01 | 1093557 | DXCM | 10-Q | Url |
| 2025-02-18 | 1093557 | DXCM | 10-K | Url |
| 2024-10-24 | 1093557 | DXCM | 10-Q | Url |
| 2024-07-25 | 1093557 | DXCM | 10-Q | Url |
| 2024-04-25 | 1093557 | DXCM | 10-Q | Url |
| 2024-02-08 | 1093557 | DXCM | 10-K | Url |
| 2023-10-26 | 1093557 | DXCM | 10-Q | Url |
| 2023-07-27 | 1093557 | DXCM | 10-Q | Url |
| 2023-04-27 | 1093557 | DXCM | 10-Q | Url |
| 2023-02-09 | 1093557 | DXCM | 10-K | Url |
| 2022-10-27 | 1093557 | DXCM | 10-Q | Url |
| 2022-07-28 | 1093557 | DXCM | 10-Q | Url |
| 2022-04-28 | 1093557 | DXCM | 10-Q | Url |
| 2022-02-14 | 1093557 | DXCM | 10-K | Url |
| 2021-10-28 | 1093557 | DXCM | 10-Q | Url |
| 2021-07-29 | 1093557 | DXCM | 10-Q | Url |
| 2021-04-29 | 1093557 | DXCM | 10-Q | Url |
| 2021-02-11 | 1093557 | DXCM | 10-K | Url |
| 2020-10-27 | 1093557 | DXCM | 10-Q | Url |
| 2020-07-28 | 1093557 | DXCM | 10-Q | Url |
| 2020-04-28 | 1093557 | DXCM | 10-Q | Url |
| 2020-02-13 | 1093557 | DXCM | 10-K | Url |
| 2019-11-06 | 1093557 | DXCM | 10-Q | Url |
| 2019-07-31 | 1093557 | DXCM | 10-Q | Url |
| 2019-05-01 | 1093557 | DXCM | 10-Q | Url |
| 2019-02-21 | 1093557 | DXCM | 10-K | Url |
| 2018-11-06 | 1093557 | DXCM | 10-Q | Url |
| 2018-08-01 | 1093557 | DXCM | 10-Q | Url |
| 2018-05-02 | 1093557 | DXCM | 10-Q | Url |
| 2018-02-27 | 1093557 | DXCM | 10-K | Url |
| 2017-11-01 | 1093557 | DXCM | 10-Q | Url |
| 2017-08-01 | 1093557 | DXCM | 10-Q | Url |
| 2017-05-02 | 1093557 | DXCM | 10-Q | Url |
| 2017-02-28 | 1093557 | DXCM | 10-K | Url |
| 2016-11-01 | 1093557 | DXCM | 10-Q | Url |
| 2016-08-02 | 1093557 | DXCM | 10-Q | Url |
| 2016-04-27 | 1093557 | DXCM | 10-Q | Url |
| 2016-02-23 | 1093557 | DXCM | 10-K | Url |
| 2015-11-04 | 1093557 | DXCM | 10-Q | Url |
| 2015-08-05 | 1093557 | DXCM | 10-Q | Url |
| 2015-04-29 | 1093557 | DXCM | 10-Q | Url |
| 2015-02-25 | 1093557 | DXCM | 10-K | Url |
| 2014-11-06 | 1093557 | DXCM | 10-Q | Url |
| 2014-08-06 | 1093557 | DXCM | 10-Q | Url |
| 2014-05-01 | 1093557 | DXCM | 10-Q | Url |
| 2014-02-20 | 1093557 | DXCM | 10-K | Url |
| 2013-11-06 | 1093557 | DXCM | 10-Q | Url |
| 2013-08-07 | 1093557 | DXCM | 10-Q | Url |
| 2013-05-01 | 1093557 | DXCM | 10-Q | Url |
| 2013-02-21 | 1093557 | DXCM | 10-K | Url |
| 2012-11-01 | 1093557 | DXCM | 10-Q | Url |
| 2012-08-06 | 1093557 | DXCM | 10-Q | Url |
| 2012-05-02 | 1093557 | DXCM | 10-Q | Url |
| 2012-02-23 | 1093557 | DXCM | 10-K | Url |
| 2011-11-02 | 1093557 | DXCM | 10-Q | Url |
| 2011-08-03 | 1093557 | DXCM | 10-Q | Url |
| 2011-05-03 | 1093557 | DXCM | 10-Q | Url |
| 2011-03-03 | 1093557 | DXCM | 10-K | Url |
| 2010-11-04 | 1093557 | DXCM | 10-Q | Url |
| 2010-08-03 | 1093557 | DXCM | 10-Q | Url |
| 2010-05-05 | 1093557 | DXCM | 10-Q | Url |
| 2010-03-09 | 1093557 | DXCM | 10-K | Url |
| 2009-11-04 | 1093557 | DXCM | 10-Q | Url |
| 2009-08-03 | 1093557 | DXCM | 10-Q | Url |
| 2009-05-06 | 1093557 | DXCM | 10-Q | Url |
| 2009-03-05 | 1093557 | DXCM | 10-K | Url |
| 2008-11-10 | 1093557 | DXCM | 10-Q | Url |
| 2008-08-05 | 1093557 | DXCM | 10-Q | Url |
| 2008-05-08 | 1093557 | DXCM | 10-Q | Url |
| 2008-03-11 | 1093557 | DXCM | 10-K | Url |
| 2007-10-30 | 1093557 | DXCM | 10-Q | Url |
| 2007-02-27 | 1093557 | DXCM | 10-K | Url |
| 2006-04-06 | 1093557 | DXCM | S-1 | Url |
| 2006-02-27 | 1093557 | DXCM | 10-K | Url |
| 2005-02-01 | 1093557 | DXCM | S-1 | Url |
DexCom, Inc(NASDAQ:DXCM) 
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company offers its systems for use by people with diabetes, as well as for use by healthcare providers. Its p...
Website: http://www.dexcom.com
Founded: 1999
Full Time Employees: 3,900
CEO: Kevin R. Sayer
Sector: Healthcare
Industry: Diagnostics & Research
The information provided in this report about DXCM stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.